What is AptarGroup, Inc. (ATR)?

AptarGroup, Inc. (ATR) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of ATR?

The current price of ATR is $126.51. Prices are updated in real time on Stocks360.

What is ATR's price-to-earnings (PE) ratio?

ATR's trailing twelve-month PE ratio is 22.59, based on current price and earnings per share data available on Stocks360.

What is ATR's market capitalization?

ATR's market capitalization is $8,043,648,630.00, placing it in the mid-cap tier.

Does ATR pay a dividend?

Yes. ATR has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

AptarGroup, Inc. (ATR)

Stock analysis · NYSE · Healthcare · Medical - Instruments & Supplies

$126.51

Market Cap

$8.04B

PE (TTM)

22.59

EPS (TTM)

N/A

Dividend Yield

1.52%

Beta

0.34

Day Range

$125.32 – $127.41

52-wk Range

$103.23 – $146.91

Avg Volume

N/A

Volume

445.07K

AptarGroup, Inc. (ATR) is a publicly traded company in the Healthcare sector. Latest price: $126.51. Market cap $8.04B. Trailing PE 22.59. Dividend yield 1.52%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $128.10 2026-10-27 · $126.51 (-1.24%)

Earnings

Most Recent

Jul 30, 2026

EPS $1.42 vs est. $1.35

Beat by $0.07

Next Earnings

Oct 29, 2026

EPS estimate $1.47

Proprietary Signals

Signal snapshot temporarily unavailable.

About AptarGroup, Inc.

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-d…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	22.59×
P/S (TTM)	2.05×
P/B	3.07×
P/FCF (TTM)	25.91×
EV / EBITDA	11.29×
EV / Sales	2.36×
Earnings Yield	4.49%
Free Cash Flow Yield	3.86%
Dividend Yield	1.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$9.28B
Revenue (TTM)	$3.93B
Net Income (TTM)	$361.04M
Free Cash Flow (TTM)	$358.27M
Net Debt	$1.24B
Working Capital	$698.27M
Gross Margin	28.26%
Operating Margin	12.37%
Net Margin	9.22%
Return on Equity	13.52%
Return on Invested Capital	9.15%